Back to MORGAN STANLEY MORGAN STANLEY

TBPHTBPH
8 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in THERAVANCE BIOPHARMA INC

MORGAN STANLEY holds 510,272 shares of TBPH (THERAVANCE BIOPHARMA INC), worth $8.3M as of 2026-Q1. The position was decreased (-36.5% shares). TBPH represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$8.3M

Current Shares

510,272

Total Value Change

+$4.4M

Total Shares Change

+51,349

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
510,272
-36.5%
$8.3M0.0%$13.96
0
2025-Q4
Increased
803,119
+34.0%
$15M0.0%$18.91
36
2025-Q3
Increased
599,551
+8.9%
$8.8M0.0%$14.43
30
2025-Q2
Increased
550,607
+43.0%
$6.1M0.0%$11.22
36
2025-Q1
Decreased
384,987
-1.9%
$3.4M0.0%$9.23
0
2024-Q4
Decreased
392,333
-20.9%
$3.7M0.0%$9.47
0
2024-Q3
Increased
495,813
+8.0%
$4M0.0%$8.10
29
2024-Q2
New
458,923
-
$3.9M0.0%$8.48
37

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used